Prostate Cancer Management in the UK and Other European Countries: A Systematic Review

References (54)

1. 1 Global cancer statistics [DOI]
2. 2 Cancer statistics, 2011 [DOI]
3. 3 Screening and Prostate-Cancer Mortality in a Randomized European Study [DOI]
4. 4 Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer [DOI]
5. 5 Radical Prostatectomy versus Observation for Localized Prostate Cancer [DOI]
6. 6 Designing Clinical Research
7. 7 20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer [DOI]
8. 8 Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) [DOI]
9. 9 Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update [DOI]
10. 10 Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer [DOI]
11. 11 Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy [DOI]
12. 12 A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer [DOI]
13. 13 Quality of Life after Radical Prostatectomy or Watchful Waiting [DOI]
14. 14 Surgical risk factors, morbidity, and mortality in elderly patients [DOI]
15. 15 Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer [DOI]
16. 16 Comparison of Recommendations by Urologists and Radiation Oncologists for Treatment of Clinically Localized Prostate Cancer [DOI]
17. 17 Active surveillance for the management of prostate cancer in a contemporary cohort [DOI]
18. 18 12-Year Outcomes Following Permanent Prostate Brachytherapy in Patients with Clinically Localized Prostate Cancer [DOI]
19. 19 Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With Cancer [DOI]
20. 20 Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality [DOI]
21. 21 Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials [DOI]
22. 22 Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma [DOI]
23. 23 Osteoporosis in Men [DOI]
24. 24 Benefits and Risks of Bisphosphonate Therapy for Osteoporosis [DOI]
25. 25 Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology [DOI]
26. 26 Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer [DOI]
27. 27 Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies [DOI]
28. 28 Prostate Cancer Overview [DOI]
29. 29 Management of Advanced Prostate Cancer After First-Line Chemotherapy [DOI]
30. 30 Who can best recruit to randomized trials? [DOI]
31. 31 Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space [DOI]
32. 32 Prostate Cancer: A Practical Approach to Current Management of Recurrent Disease [DOI]
33. 33 Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments [DOI]
34. 34 A qualitative study evaluating experiences of a lifestyle intervention in men with prostate cancer undergoing androgen suppression therapy [DOI]
35. 35 Radical prostatectomy versus watchful waiting for prostate cancer [DOI]
36. 36 Stereotactic Body Radiotherapy in Prostate Cancer: Is Rapidarc a Better Solution than Cyberknife? [DOI]
37. 37 PRISMAtic reporting of systematic reviews and meta-analyses [DOI]
38. 38 Evaluation of an evidence-based education package for men with prostate cancer on hormonal manipulation therapy [DOI]
39. 39 Testis and prostate cancer incidence in ethnic groups in South East England [DOI]
40. 40 Diethylstilbestrol (DES) retains activity and is a reasonable option in patients previously treated with docetaxel for castration-resistant prostate cancer [DOI]
41. 41 Prostate cancer overview. Part 2: metastatic prostate cancer [DOI]
42. 42 Management Strategies for Locally Advanced Prostate Cancer [DOI]
43. 43 Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer [DOI]
44. 44 Advanced prostate cancer: treatment and patient-centred care [DOI]
45. 45 The management of metastatic prostate cancer [DOI]
46. 46 Prostate cancer – presentation, diagnosis and treatment: what does the literature say? [DOI]
47. 47 Pharmacological treatment of patients with advanced prostate cancer [DOI]
48. 48 Radiation Therapy for Clinically Localized Prostate Cancer [DOI]
49. 49 Male Accessory Sex Organs: Structure and Function in Mammals
50. 50 Epidemiology, Pathology and Pathogenesis [DOI]
51. 51 An Evaluation of the Decreasing Incidence of Positive Surgical Margins in a Large Retropubic Prostatectomy Series [DOI]
52. 52 The Little Black Book of Urology
53. 53 Diagnosis and treatment of patients with prostate cancer: the nurse’s role [DOI]
54. 54 [What is prostate cancer?].

Cited by 0

No indexed citations yet.

Related research

• Maternal Age and Congenital Anomalies among Newborns in a Tertiary Health Facility in Benue State, North Central Nigeria — shares topic coverage
• Early Diagnosis of Neonatal Sepsis: A Review of the Current Methods in Clinical Practice — shares topic coverage
• Skeletal Dysplasia: Approach to Simplify Diagnosis, Looking for Radiographic Clue Signs — shares topic coverage
• Impact of Radiology on the Early Identification of Waterhouse-friderichsen Syndrome: A Case Study — shares topic coverage
• The Impact of Genexpert MTB/RIF Technology on the Minimization of Tuberculosis: A Review of Literature — shares topic coverage